Influence of mesenchymal stem cells on metastasis development in mice in vivo

Stem Cell Research and Therapy

Volumn 6, Issue 1, 2015, Pages

  Meleshina, Aleksandra V ^a,b   Cherkasova, Elena I ^a,b   Shirmanova, Marina V ^a   Klementieva, Natalia V ^a   Kiseleva, Ekaterina V ^c   Snopova, Ludmila B ^a   Prodanets, Natalia N ^a   Zagaynova, Elena V ^a,b  

^a PRIVOLZHSKY RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^b LOBACHEVSKY STATE UNIVERSITY OF NIZHNY NOVGOROD   (Russian Federation)

^c KOL TSOV INSTITUTE OF DEVELOPMENTAL BIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; FIREFLY LUCIFERASE; HERMES ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; RED FLUORESCENT PROTEIN; THY 1 ANTIGEN; CONDITIONED MEDIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BLOOD DONOR; BONE MARROW CELL; BREAST CANCER CELL LINE; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; FEMALE; FLUORESCENCE IMAGING; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LUMINESCENCE; LUNG METASTASIS; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL INOCULATION; ANIMAL; BREAST TUMOR; CANCER TRANSPLANTATION; CELL TRANSFORMATION; CONDITIONED MEDIUM; DISEASE MODEL; LUNG TUMOR; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; NUDE MOUSE; PATHOLOGY; PHARMACOLOGY; PROCEDURES; SECONDARY;

ANIMALIA; MUS; MUS MUSCULUS;

ANIMALS; BREAST NEOPLASMS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CULTURE MEDIA, CONDITIONED; DISEASE MODELS, ANIMAL; FEMALE; LUNG NEOPLASMS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; OPTICAL IMAGING;

EID: 84928568086     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/s13287-015-0003-7     Document Type: Article

References (51)

1. Spaeth EL, Klopp A, Dembinski J, Andreeff M, Marini F. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther. 2008;15:730-8.
2. Komarova S, Kawakami Y, Stoff-Khalili MA. Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses. Mol Cancer Ther. 2006;5:755-66.
3. Ren C, Kumar S, Chanda D. Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model. Stem Cells. 2008;26:2332-8.
4. Niess H, Bao Q, Conrad C. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissuespecific suicide gene expression suppresses growth of hepatocellular carcinoma. Ann Surg. 2011;254:767-74.
5. Stagg J. Mesenchymal stem cells in cancer. Stem Cell Rev. 2008;4:119-24.
6. Roorda BD, TerElst A, Kamps WA, Bont ES. Bone marrow-derived cells and tumor growth:contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells. Crit Rev Oncol Hematol. 2009;69:187-98.
7. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature. 2004;432:332-7.
8. Hu M, Polyak K. Molecular characterisation of the tumour microenvironment in breast cancer. Eur J Cancer. 2008;44:2760-5.
9. Martin FT, Dwyer RM, Kelly J, Khan S, Murphy JM, Curran C. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat. 2010;124:317-26.
10. Hugo H, Ackland ML, Blick T. Epithelial-mesenchymal and mesenchymal - epithelial transitions in carcinoma progression. J Cell Physiol. 2007;213:374-83.
11. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008;14:818-29.
12. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, et al. Mesenchymal stem cells within tumor stroma promote breast cancer metastasis. Nature. 2007;449:557-63.
13. Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H, et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther. 2004;11:1155-64.
14. Qiao L, Xu Z, Zhao T, Ye L, Zhang X. Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signaling. Cancer Lett. 2008;269:67-77.
15. Ma Y, Hao X, Zhang S, Zhang J. The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells. Breast Cancer Res Treat. 2012;133:473-85.
16. Stoff-Khalili MA, Rivera AA, Mathis JM, Banerjee NS, Moon AS, Hess A, et al. Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma. Breast Cancer Res Treat. 2007;105:157-67.
17. Ling X, Marini F, Konopleva M, Schober W, Shi Y, Burks J, et al. Mesenchymal stem cells overexpressing IFN-β inhibit breast cancer growth and metastases through Stat3 signaling in a syngeneic tumor model. Cancer Microenviron. 2010;3:83-95.
18. Qiao L, Zhao TJ, Wang FZ, Shan CL, Ye LH, Zhang XD. NF-kappaB downregulation may be involved the depression of tumor cell proliferation mediated by human mesenchymal stem cells. Acta Pharmacol Sin. 2008;29:333-40.
19. Loebinger MR, Janes SM. Stem cells as vectors for antitumour therapy. Thorax. 2010;65:362-9.
20. Wang ML, Pan CM, Chiou SH, Chen WH, Chang HY, Lee OK, et al. Oncostatin m modulates the mesenchymal-epithelial transition of lung adenocarcinoma cells by a mesenchymal stem cell-mediated paracrine effect. Tumor Stem Cell Biol. 2012;72:6051-64.
21. Liu J, Han G, Liu H, Qin C. Suppression of cholangiocarcinoma cell growth by human umbilical cord mesenchymal stem cells: a possible role of Wnt and Akt signaling. PLoS One. 2013;8:e62844.
22. Hou L, Wang X, Zhou Y, Ma H, Wang Z, He J, et al. Inhibitory effect and mechanism of mesenchymal stem cells on liver cancer cells. Tumour Biol. 2014;35:1239-50.
23. Zhao C, Tian M, Zhang H. In vivo stem cell imaging. The Open Nucl Med J. 2010;2:171-7.
24. Gao Y, Cui Y, Chan JKY, Xu C. Stem cell tracking with optically active nanoparticles. Am J Nucl Med Mol Imaging. 2013;3:232-46.
25. Zhou Y, Shao G, Liu S. Monitoring breast tumor lung metastasis by U-SPECT-II/CT with an integrinαvβ3-targeted radiotracer 99m Tc-3P-RGD2. Theranostics. 2012;2:577-88.
26. Greer LF, Szalay AA. Imaging of light emission from the expression of luciferases in living cells and organisms: a review. Luminescence. 2002;17:43-74.
27. Ruan J, Song H, Li C, Bao Ch FH, Wang K, Ni J, et al. DiR-labeled embryonic stem cells for targeted imaging of in vivo gastric cancer cells. Theranostics. 2012;2:618-28.
28. Alieva M, Bagó JR, Aguilar E, Soler-Botija C, Vila OF, Molet J, et al. Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response. PLoS One. 2012;7:e35148. doi:10.1371/journal.pone.0035148.
29. Shah K. Imaging neural stem cell fate in mouse model of glioma. Curr Protoc Stem Cell Biol. 2009 Mar;Chapter 5:Unit 5A.1. doi:10.1002/9780470151808.sc05a01s8.
30. Ke C, Liu R, Suetsugu A, Kimura H, Ho JH, Lee OK, et al. In vivo fluorescence imaging reveals the promotion of mammary tumorigenesis by mesenchymal stromal cells. PLoS One. 2013;8:e69658.
31. Wang H, Cao F, De A. Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging. Stem Cells. 2009;27:1548-58.
32. Wang Y, Li Z. Traceable therapeutic strategy for treatment of breast cancer with mesenchymal stem cells (MSCs). Cancer Cell Microenvironment. 2014;1:e198.
33. Leng L, Wang Y, He N, Wang D, Zhao Q, Feng G, et al. Molecular imaging for assessment of mesenchymal stem cells mediated breast cancer therapy. Biomaterials. 2014;35:5162-70.
34. Mandel K, Yang Y, Schambach A, Glage S, Otte A, Hass R. Mesenchymal stem cells directly interact with breast cancer cells and promote tumor cell growth in vitro and in vivo. Stem Cells Dev. 2013;22:3114-27.
35. Cuiffo BG, Karnoub AE. Mesenchymal stem cells in tumor development, Emerging roles and concepts. Cell Adhesion Migration. 2012;6:220-30.
36. Albarenque SM, Zwacka RM, Mohr A. Both human and mouse mesenchymal stem cells promote breast cancer metastasis. Stem Cell Res. 2011;7:163-71.
37. Ljujic B, Milovanovic M, Volarevic V, Murray B, Bugarski D, Przyborski S, et al. Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice. Scientific Reports. 2013;3:1-9.
38. Qiao L, Xu Z, Zhao T, Zhao Z, Shi M, Zhao RC, et al. Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Res. 2008;18:500-7.
39. Li Z, Tan F, Liewehr DJ, Steinberg SM, Thiele CJ. In vitro and in vivo inhibition of neuroblastoma tumor cell growth by AKT inhibitor perifosine. J Natl Cancer Inst. 2010;102:758-70.
40. Lu YR, Yuan Y, Wang XJ, Wei LL, Chen YN, Cong C, et al. The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo. Cancer Biol Ther. 2008;7:245-51.
41. Ohlsson LB, Varas L, Kjellman C, Edvardsen K, Lindvall M. Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix. Exp Mol Pathol. 2003;75:248-55.
42. Kim J, Escalante LE, Dollar BA, Hanson SE, Hematti P. Comparison of breast and abdominal adipose tissue mesenchymal stromal/stem cells in support of proliferation of breast cancer cells. Cancer Invest. 2013;31:550-4.
43. Fierro FA, Sierralta WD, Epunan MJ, Minguell JJ. Marrow-derived mesenchymal stem cells: role in epithelial tumor cell determination metastasis. Clin Exp. 2004;21:313-9.
44. Gauthaman K, Yee FC, Cheyyatraivendran S, Biswas A, Choolani M, Bongso A. Human umbilical cord Wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro. J Cell Biochem. 2012;113:2027-39.
45. Ono M, Kosaka N, Tominaga N, Yoshioka Y, Takeshita F, Takahashi RU, et al. Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. Sci Signal. 2014;7:ra63.
46. Yang C, Lei D, Ouyang W, Ren J, Li H, Hu J, et al. Conditioned media from human adipose tissue-derived mesenchymal stem cells and umbilical cord-derived mesenchymal stem cells efficiently induced the apoptosis and differentiation in human glioma cell lines in vitro. Biomed Res Int. 2014;2014:109389. doi:10.1155/2014/109389.
47. Abd-Allah SH, Shalaby SM, El-Shal AS, Elkader EA, Hussein S, Emam E, et al. Effect of bone marrow-derived mesenchymal stromal cells on hepatoma. Cytotherapy. 2014;16:1197-206.
48. Takahara K, Ii M, Inamoto T, Komura K, Ibuki N, Minami K, et al. Adipose-derived stromal cells inhibit prostate cancer cell proliferation inducing apoptosis. Biochem Biophys Res Commun. 2014;446:1102-7.
49. Khakoo AY, Pati S, Anderson SA, Reid W, Elshal MF, Rovira II, et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med. 2006;203:1235-47.
50. Jenkins DE, Hornig YS, Oei Y, Dusich J, Purchio T. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice. Breast Cancer Res. 2005;7:444-54.
51. Kidd S, Spaeth E, Dembinski JL. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells. 2009;27:2614-23.